Literature DB >> 1861865

Membrane-anchored forms of EGF stimulate focus formation and intercellular communication.

Y Dobashi1, D F Stern.   

Abstract

Epidermal growth factor (EGF) is the prototype for a small family of soluble proteins that bind to and activate the EGF receptor. These proteins are derived from larger propeptides that are anchored to the plasma membrane. Although the signalling properties of soluble EGF are well-characterized, the signalling potential of the membrane-anchored form had not been determined. We therefore investigated whether membrane-anchored EGF can stimulate the EGF receptor. An EGF mini-gene expression system that we had previously constructed for expression of soluble EGF was modified to encode anchored forms of EGF. In the encoded proteins EGF was fused to the spacer in the EGF propeptide that separates EGF from the transmembrane domain. The spacer was followed by vesicular stomatitis virus G protein transmembrane and cytoplasmic domain sequences. Three forms of EGF/G fusion protein were expressed in rat fibroblasts. The plasmids for expression of anchored EGF induced focus formation in rat fibroblasts, indicating that anchored EGF can cause autocrine transformation. When mixed with indicator HeLa cells, cell lines expressing EGF/G fusion proteins activated the HeLa EGF receptor. This activation was mediated by cell-associated, rather than soluble EGF. The finding that membrane-anchored EGF is capable of activating the EGF receptor on neighboring cells has broad implications for the functions of EGF in the organism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861865

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  The extracellular linker of pro-neuregulin-alpha2c is required for efficient sorting and juxtacrine function.

Authors:  Juan C Montero; Ruth Rodríguez-Barrueco; Laura Yuste; Pedro P Juanes; Joana Borges; Azucena Esparís-Ogando; Atanasio Pandiella
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

Review 2.  EGFR signaling in breast cancer: bad to the bone.

Authors:  John Foley; Nicole K Nickerson; Seungyoon Nam; Kah Tan Allen; Jennifer L Gilmore; Kenneth P Nephew; David J Riese
Journal:  Semin Cell Dev Biol       Date:  2010-09-09       Impact factor: 7.727

3.  The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.

Authors:  G P Briley; M A Hissong; M L Chiu; D C Lee
Journal:  Mol Biol Cell       Date:  1997-08       Impact factor: 4.138

4.  The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion.

Authors:  B A Thorne; G D Plowman
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

5.  Activated release of membrane-anchored TGF-alpha in the absence of cytosol.

Authors:  M W Bosenberg; A Pandiella; J Massagué
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

Review 6.  Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles.

Authors:  Laura C Zanetti-Domingues; Scott E Bonner; Marisa L Martin-Fernandez; Veronica Huber
Journal:  Cells       Date:  2020-11-19       Impact factor: 6.600

7.  A subdomain in the transmembrane domain is necessary for p185neu* activation.

Authors:  H Cao; L Bangalore; B J Bormann; D F Stern
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

8.  Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial.

Authors:  Jun Liang; Mingyan E; Gang Wu; Lujun Zhao; Xia Li; Xia Xiu; Ning Li; Bo Chen; Zhouguang Hui; Jima Lv; Hui Fang; Yu Tang; Nan Bi; Wenqing Wang; Yirui Zhai; Tao Li; Dongfu Chen; Shuangmei Zou; Ning Lu; Rolando Perez-Rodríguez; Junqi Zheng; Luhua Wang
Journal:  Onco Targets Ther       Date:  2013-11-06       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.